/stocks — the workspaceLOADING
All ARX SEC filings, by type → · Earnings date & implied move · Search inside filings
ARX is not among the 142 companies we ingest every day, so it is not in the fundamentals screener or the size and group lists built from it. This page reads its SEC filings when the page is built. Ask us to add it: we keep a count per ticker and nothing about you.
Latest report (10-Q, filed 2026-08-13). Three months to 2026-06-30 against 2025-06-30: Revenue $356.9M, up 62.9% from $219.1M; Net income $80.0M, up 510.7% from $13.1M. Read it line by line, each linked to its source → · Every report →
Accelerant Holdings (ARX) is a insurance agents, brokers & service company. Health scores are not assessed for a financial company. 3 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-11-11 from ARX's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
Every filed figure on this page is free to read, dated and sourced; no column is held back for a paid plan. Each section with figures says what date they are true as of and where they come from.
What’s behind ARX’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Has ARX been issuing shares? Offering history →
Volume against its own history: 1% of its last 252 sessions were lighter than the last one, the 2026-11-06 session. End-of-day bars (Databento). Volume detail
Not assessed. The F-, Z- and M-Scores were all derived on non-financial companies and their authors excluded financials. For an insurer they measure the shape of the business, not its health. We would rather report nothing than report a number that does not transfer.
| Diluted EPS | That year | Year before, same report | Change | Report |
|---|---|---|---|---|
| fiscal 2025 | -7.49 USD | 0.14 USD | not a growth rate (a year at or below zero) | 10-K filed 2026-03-18 |
Concepts read: us-gaap:EarningsPerShareDiluted
Per filed share, as each report states it. Free cash flow per share is operating cash flow less capital expenditure, over the diluted weighted average share count (or net income over diluted EPS where the count is tagged per share class).
Each year’s change comes from one annual report, which states that year and the year before on the same share basis, and the rate compounds those changes; so a split or a restatement between reports cannot bend it. A rate needs a positive figure at both ends of its window. The DCF above grows total free cash flow and divides by today’s share count, so a per-share rate also carries the buybacks or new shares of those years. These are past figures, not a forecast.
Not shown yet: the P/E range ARX has traded at, which would set the discount rate and terminal assumptions against its own history. It needs a long daily price history we are not yet licensed to display.
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from ARX’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
↓ Download the fiscal-year statement table: XLSX · CSV · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
As filed. We do not recategorize line items. Each chart plots one XBRL concept exactly as ARX tagged it: revenue us-gaap:Revenues, net income us-gaap:ProfitLoss, EPS us-gaap:EarningsPerShareDiluted, period by period; a period the company did not tag on its own is left out, not estimated. A figure that disagrees with the filing is a bug in our extraction, not a policy, and we fix it: report a mismatch.
A plain-English read on ARX plus an auto-SWOT, built from ARX's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts, a bull, a bear, a risk manager, and a PM, debate ARX using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Ask about ARX’s revenue, earnings, valuation, filings, insiders or Congress trades. Answers come only from the numbered evidence the research brief uses, each citing the items it rests on. A question about one figure is answered by code, free. One that puts figures together is 1 generation (Pro). A question about whether to buy, sell or hold, how much, or where the price goes gets a refusal.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Closes only, split-adjusted. An average needs that many sessions on file to print. These are measurements, not support, resistance or targets. Chart with studies
Daily closes from 2025-07-24 through 2026-11-06, 326 sessions, split-adjusted. No direction, pattern, entry, target or overbought label: these are measurements. Filings dated on the move days are in ARX’s filings; the chart with studies draws every figure.
Written by code from 326 end-of-day bars through 2026-11-06. Written by code from the data on file, not by a model. Information, not investment advice: it describes the security and recommends nothing to anyone.
Projected from ARX's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentARX files or announces.
ARX has rallied after 4 of its last 5 earnings reports.
Each figure is one earnings reaction — how much ARX moved from the closing price the day before a report to the close the day after. Based on its last 5 reports.
Large earnings reactions have been common.
ARX has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+43.9% and -31.5%).
A more typical earnings reaction has been approximately ±9.7%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-08-13 | +43.9% |
| 2026-05-13 | +8.3% |
| 2026-03-18 | +4.7% |
| 2025-11-12 | +9.7% |
| 2025-08-28 | -31.5% |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
On file for ARX from Nov 9, 2026 to Nov 22, 2026: earnings date and filing deadline (below).
| Event | Result |
|---|---|
| Earnings date | on file. ARX reports: Nov 11 (projected from past report dates, not company-confirmed; window Nov 6 to Nov 16). source |
| Filing deadline | on file. In the window: the 10-Q for the quarter ending Sep 30, 2026, due 40 to 45 days after it as SEC states no filer status for it, the span covers every status, falls due between Nov 9, 2026 and Nov 16, 2026. Newest periodic report on file: the 10-Q for the period ending Jun 30, 2026, filed Aug 13, 2026. filing list on EDGAR |
| Ex-dividend date | not covered. Not checked. This attestation does not cover ex-dividend dates. |
This records what these sources returned when they were read. It is not a forecast: a company can announce an event at any time, and ex-dividend dates are not covered. Window 2026-11-09 to 2026-11-22, Eastern dates. Deadlines follow SEC Rules 13a-1 and 13a-13 and Form 20-F, moved past weekends and federal holidays by Rule 0-3.
2 of the 2 checks that ran found nothing new for ARX. 2 could not run.
Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.
None of the 5 estimators could run on ARX's filings.
One estimator is a point estimate, not a range, so no band and no valuation label are published for ARX. Below is everything that was checked, so the refusal can be read rather than taken on trust.
Nothing produced a value.
1 fiscal year of price history was on record; the historical multiples need 5. No sector peer set is priced for ARX, so sector medians could not fill the gaps.
Every refusal recorded for ARX → · How often we decline, and why →
Total return including reinvested dividends, from ARX’s adjusted closing prices. Past return is not a forecast and not investment advice.
Every figure is from ARX’s SEC cash-flow statement. This describes how management deployed cash last period — it is not a grade of that deployment, not a forecast, and not investment advice. Whether reinvesting, paying down debt, or returning cash was the right call depends on the return each earns, which the filings do not settle. Educational information only.
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.
Group: Insurance Agents, Brokers & Service, the SEC industry code ARX files under. 1 company in our stored table files under it.
| Metric | ARX | Group median | 25th to 75th percentile | Where ARX sits |
|---|---|---|---|---|
| Net marginnet income divided by revenue, same fiscal year | Not computed for banks and insurers: their revenue is interest, fees and premiums, not sales, so a margin on it does not compare with other industries or within theirs. | |||
| Free cash flow marginoperating cash flow less capital expenditure, divided by revenue, same fiscal year | Not computed for banks and insurers: their revenue is interest, fees and premiums, not sales, so a margin on it does not compare with other industries or within theirs. | |||
| Return on equitynet income divided by stockholders’ equity at the fiscal year end | Withheld: 1 company in this SIC group has the figure on file, and a group prints from 6. | |||
One filed metric per row, each a ratio of two figures from the same annual report; no composite and no grade. Percentile is the share of the group’s other companies with a lower figure. A group prints from 6 companies with the figure. The group is drawn from our stored table (the S&P 500 issuers and the companies we cover, each with its newest annual report read), not from every filer in the class. Industry pages show the same medians by group.
Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30, not today.
| Fund | Weight | As of |
|---|---|---|
| IWM iShares Russell 2000 ETF | 0.02% | 2026-06-30 |
| VTI Vanguard Total Stock Market ETF | <0.01% | 2026-06-30 |
Drawn from 38 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.
Head office: Cayman Islands
Source: the cover page of Accelerant Holdings’s 10-Q filed 2026-08-13, on EDGAR. Filings checked 2026-11-09. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works
No tracked institution reported a position in ARX in the latest 13F round.
Of 17 sales in the last ~6 months, 16 were filed with the Rule 10b5-1 box checked, set up in advance under a written trading plan; 1 was filed without it.
| Meriwether Karen SueDirector | SELL | $11K | view → |
| Hasley NancyDirector | SELLplan | $401K | view → |
| ONeill Francis JamesCo-Founder, Chief U/W Officer | SELLplan | $1.9M | view → |
| RADKE JEFFREY LCo-Founder, CEO | SELLplan | $967K | view → |
| RADKE JEFFREY LCo-Founder, CEO | SELLplan | $965K | view → |
| ONeill Francis JamesCo-Founder, Chief U/W Officer | SELLplan | $3.1M | view → |
| RADKE JEFFREY LCo-Founder, CEO | SELLplan | $1.4M | view → |
| Sternberg Matthew DavidCOO, Risk Exchange | SELLplan | $257K | view → |
No lawmaker has disclosed a trade in ARX under the STOCK Act.